当前位置:首页 - 行情中心 - 戴维医疗(300314) - 财务分析 - 现金流量表

戴维医疗

(300314)

  

流通市值:16.07亿  总市值:32.20亿
流通股本:1.44亿   总股本:2.88亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金282,349,029.21117,130,804.5612,963,275.76395,264,661.47
  收到的税费返还4,422,408.422,065,681.696,511,048.435,248,645.79
  收到其他与经营活动有关的现金10,971,250.163,949,934.9621,158,502.9121,626,293.77
  经营活动现金流入小计297,742,687.79123,146,421.15640,632,827.1422,139,601.03
  购买商品、接受劳务支付的现金157,369,208.3781,213,953.22267,704,483.66203,651,729.52
  支付给职工以及为职工支付的现金82,549,768.1851,019,533.15136,610,358.83101,116,347.09
  支付的各项税费15,548,386.8910,604,441.9527,361,966.821,255,721.24
  支付其他与经营活动有关的现金38,656,56817,767,601.94119,706,282.3381,311,564.78
  经营活动现金流出小计294,123,931.44160,605,530.26551,383,091.62407,335,362.63
  经营活动产生的现金流量净额3,618,756.35-37,459,109.1189,249,735.4814,804,238.4
二、投资活动产生的现金流量:
  收回投资收到的现金322,580-1,236,325.17-
  取得投资收益收到的现金5,667,993.76,881,042.115,155,676.21134,837,568.4
  处置固定资产、无形资产和其他长期资产收回的现金净额--428,776.4956,548.67
  收到的其他与投资活动有关的现金334,487,432.33190,000,043.541,174,900,000808,530,027.4
  投资活动现金流入小计340,478,006.03196,881,085.641,191,720,777.87943,424,144.47
  购建固定资产、无形资产和其他长期资产支付的现金25,380,739.038,236,153.9155,028,105.150,594,306.26
  支付其他与投资活动有关的现金326,752,229167,842,2081,086,221,955.93820,229,333.32
  投资活动现金流出小计352,132,968.03176,078,361.911,141,250,061.03870,823,639.58
  投资活动产生的现金流量净额-11,654,96220,802,723.7350,470,716.8472,600,504.89
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金23,040,000-25,056,00025,056,000
  支付其他与筹资活动有关的现金1,721,237.04-3,442,474.081,721,237.04
  筹资活动现金流出平衡项目0-00
  筹资活动现金流出小计24,761,237.04-28,498,474.0826,777,237.04
  筹资活动产生的现金流量净额平衡项目0-00
  筹资活动产生的现金流量净额-24,761,237.04--28,498,474.08-26,777,237.04
四、汇率变动对现金及现金等价物的影响-10,900,629.87-4,835,763.62-4,870,468.09-1,641,416.03
五、现金及现金等价物净增加额-43,698,072.56-21,492,149106,351,510.1558,986,090.22
  加:期初现金及现金等价物余额437,912,682.3437,912,682.3331,561,172.15331,561,172.15
  期末现金及现金等价物余额394,214,609.74416,420,533.3437,912,682.3390,547,262.37
补充资料:
  净利润24,087,957.38-87,053,319.69-
  资产减值准备1,190,040.71-3,464,284.63-
  固定资产和投资性房地产折旧10,137,617.85-20,612,104.47-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧10,137,617.85-20,612,104.47-
  无形资产摊销1,507,497.06-1,695,591.67-
  长期待摊费用摊销2,080,224.4-4,431,952.12-
  处置固定资产、无形资产和其他长期资产的损失-19,008.79-389,071.48-
  固定资产报废损失2,858.7-22,888.26-
  公允价值变动损失-4,179,684.59--1,777,206.29-
  财务费用16,092,967.75-5,007,265.63-
  投资损失-1,761,581.5--13,529,780.77-
  递延所得税974,509.03-286,116.62-
  其中:递延所得税资产减少974,509.03-286,116.62-
  存货的减少-29,483,908.62--18,995,782.74-
  经营性应收项目的减少-6,400,701.62--25,969,746.91-
  经营性应付项目的增加-12,019,964.15-23,739,792.14-
  现金的期末余额394,214,609.74-437,912,682.3-
  减:现金的期初余额437,912,682.3-331,561,172.15-
  现金及现金等价物的净增加额-43,698,072.56-106,351,510.15-
公告日期2026-08-212026-04-232026-04-032025-10-23
审计意见(境内)标准无保留意见
TOP↑